source clustersSource Clusters is the single source of information on regional development in the life sciences sector worldwide.

With content providing broad overviews as well as in-depth coverage of business development trends, company activities, life science cluster collaborations, multi-partner scientific projects and its extensive news coverage, Source Clusters presents the latest management, research, technology and regional development information serving the needs of executives in the internationally growing life sciences sector.

Source Clusters is the essential resource for companies, incubators, science parks, clusters and regional development agencies looking to find a new location or attract new business and exploit new opportunities across the life sciences sector.

Owlstone Medical partners with Shanghai Renji Hospital to pioneer Breath Biopsy lung cancer trial

Owlstone Medical partners Shanghai Renji signing 23.3.19Global diagnostics company Owlstone Medical Ltd, which is developing a breathalyser for applications in early disease detection and precision medicine, and Shanghai Renji Hospital in China have formed a collaboration to conduct a clinical trial into the early detection of lung cancer. The collaboration is supported by the Li Ka Shing Foundation.

Recognising the escalating incidence of lung cancer in China, the partners say they have a mutual interest in developing and making accessible diagnostics for the early detection of disease, which can result in the reduction of health care costs to patients and providers and an overall increase in survival rates. They have therefore agreed to jointly conduct a first-of-its-kind clinical trial in China into the early detection of lung cancer, which will be led by Professor Li-wei Wang, Director of Oncology at Renji Hospital.

In addition, a Breath Biopsy laboratory will be established to support the study. Renji Hospital will provide operational support and Owlstone Medical will provide its Breath Biopsy technology, including breath collection stations, analytical instrumentation, and the procedures and training necessary to support the lab’s operation. Beyond this study, the lab will support additional research investigations in cancer and other areas.

For further information about Owlstone Medical visit www.owlstonemedical.com and for further information about Renji Hospital visit www.renji.com

Last modified onThursday, 11 April 2019 10:14

Latest from Tom Mulligan